Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

Clinical trial NCT06063057 · COMPLETED

Trial details

NCT number: NCT06063057
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hand, Foot and Mouth Disease Herpangina

Start date: 2023-09-20
Primary completion: 2025-12-19
Enrollment: 744

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.